Adverum Biotechnologies Inc
ADVM4.360USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
95.92MMarket Cap
LossP/E TTM
Adverum Biotechnologies Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
1.00M
-72.22%
EPS(YoY)
-6.62
45.36%
Analyst Rating
HOLD
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its total revenue reached 1.00M, with a year-on-year change of -72.22%.
What is the Earnings Per Share (EPS) of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -6.618, with a year-on-year change of 45.36%.
What is the net income of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its net income was -130.93M, with a year-on-year change of -7.22%.
What is the net margin of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its net profit margin was -13092.70%, with a year-on-year change of -285.97%.
What is the gross margin of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its Return on Equity (ROE) was -189.84%, with a year-on-year change of -93.34%.
What is the Return on Assets (ROA) of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its Return on Assets (ROA) was -78.02%, with a year-on-year change of -48.28%.
What is the operating profit of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its operating profit was -139.16M, with a year-on-year change of -7.92%.
What are the current assets of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its current assets were 131.30M, with a year-on-year change of 27.76%.
What are the total assets of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its total assets of Adverum Biotechnologies Inc were 179.84M, with a year-on-year change of 15.45%.
What are the total liabilities of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its total liabilities of Adverum Biotechnologies Inc were 109.13M, with a year-on-year change of 23.24%.
What is the total equity of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its total equity of Adverum Biotechnologies Inc was 70.71M, with a year-on-year change of 5.19%.
What is the net operating income of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its net operating income of Adverum Biotechnologies Inc was -130.93M, with a year-on-year change of -7.22%.
What is the net investment of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its net investment of Adverum Biotechnologies Inc was -41.89M, with a year-on-year change of -143.24%.
What is the net financing of Adverum Biotechnologies Inc?
According to Adverum Biotechnologies Inc's FY2024 earnings report, its net financing of Adverum Biotechnologies Inc was 120.00M, with a year-on-year change of 173817.39%.
